Two late-stage clinical trials of a drug for Alzheimer’s disease have been stopped because they aren’t likely to produce promising results, two companies involved with the research announced Thursday.
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.
Reason for hope as World Alzheimer’s Month continues
By
Lois A. Bowers
Sep 23, 2019
Days before World Alzheimer’s Day, which was Saturday, some bad news arrived about the search for a treatment. But there still are reasons for hope in the battle against Alzheimer’s.
2023 proved to be a ‘landmark’ year in progress toward treatment of Alzheimer’s disease
By
Kimberly Bonvissuto
Dec 15, 2023
The 2023 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday, highlighting “landmark” progress made over the past year in understanding...
We need to do better for people living with dementia
By
Rob Liebreich
Feb 26, 2024
With 97% of income for those with dementia going to care costs, we need to do better. Senior living and care should be the No. 1 force for change.
$625,000 stipend will continue work to alter perceptions of aging, dementia
By
Lois A. Bowers
Oct 05, 2016
Anne Basting’s work to improve older adults’ quality of life and change perceptions related to aging and dementia recently received a big boost in the form of a $625,000 “genius grant”...
FDA delays decision on new Alzheimer’s drug
Mar 08, 2024
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely...
Increased risk of Alzheimer’s in older adults with COVID a ‘scary prospect’ for senior living providers
By
Kimberly Bonvissuto
Sep 23, 2022
Older adults previously infected with COVID-19, especially women aged 85 or more years, show a substantially higher risk of developing Alzheimer’s disease within a year, according to the results of a...
Failing to cover Alzheimer’s therapies a costly proposition: researchers
By
Kimberly Bonvissuto
Jun 16, 2023
Not managing Alzheimer’s disease and related dementias is a costly proposition not just to families, but also to society, according to two recent studies.
Illinois first state to require dementia diagnosis training for healthcare professionals
By
Kimberly Bonvissuto
Aug 20, 2021
Illinois is the first state in the nation to require Alzheimer’s diagnosis training for healthcare professionals, officials said this week, thanks to a new law signed by Gov. JB Pritzker on Monday.